An academic centre for gene therapy research with clinical grade manufacturing capability

Annals of Medicine

Volumn 29, Issue 6, 1997, Pages 579-583

  Islam, Khalid B ^a   Blomberg, Pontus ^a   Wikström, Kristina ^a   Smith, C I Edvard ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Gene therapy; Good manufacturing practice; Nonviral vectors; Viral vectors

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE; PLASMID VECTOR;

ANGIOPLASTY; CANCER; CLINICAL RESEARCH; CONFERENCE PAPER; CYSTIC FIBROSIS; EXPRESSION VECTOR; GENE THERAPY; GENETIC DISORDER; GOOD MANUFACTURING PRACTICE; INFECTION; PRIORITY JOURNAL; RESTENOSIS; RETROVIRUS; SWEDEN; TEACHING HOSPITAL;

EID: 0031419683     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.3109/07853899709007486     Document Type: Conference Paper

References (20)

1. Medicines Control Agency. Rules and Guidance for Pharmaceutical Manufacturers. London: Her Majesty's Stationery Office, 1993.
2. Björkstrand B, Gahrton G, Dilber MS, Ljungman P, Smith CIE, Xauthopoulos KG. Retroviral-mediated gene transfer of CD34-enriched bone marrow and peripheral blood cells during autologous stem cell transplantation for multiple myeloma. Hum Gene Ther 1994; 5: 1279-86.
3. Dilber MS, Abedi MR, Björkstrand B, et al. Suicide gene therapy for plasma cell tumors. Blood 1996; 88: 2192-200.
4. Dilber MS, Smith CIE. Suicide genes and bystander killing: local and distant effects. Gene Ther 1997; 4: 273-4.
5. Wilson KM, Stambrook PJ, Bi WL, Pavelic ZP, Pavelic L, Gluckmann JL. HSV-tk gene therapy in head and neck squamous cell carcinoma. Enhancement by the local and distant bystander effect. Arch Otolaryngol Head Neck Surg 1996; 122: 746-9.
6. Dilber MS, Abedi MR, Christensson B, et al. Gap junctions promote the bystander effect of herpes simplex virus thymidine kinase in vivo. Cancer Res 1997; 57: 1523-8.
7. Vetrie D, Vorechovsky I, Sideras P, et al. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature 1993; 361: 226-33.
8. Thomas JD, Sideras P, Smith CIE, Vorechovosky I, Chapman V, Paul WE. Colocalization of X-linked agammaglobulinemia and X-linked immunodeficiency genes. Science 1993; 261: 355-8.
9. Ferrara N, Henzel WJ. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 1989; 161: 851-8.
10. Ferrara N. The role of vascular endothelial growth factor in pathological angiogenesis. Breast Cancer Res Treat 1995; 36: 127-37.
11. Isner JM, Pieczek A, Schainfeld R, et al. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb. Lancet 1996; 348: 370-4.
12. Isner JM, Walsh K, Rosenfield K, et al. Arterial gene therapy for restenosis. Hum Gene Ther 1996; 7: 989-1011.
13. Ulmer JB, Donnelly JJ, Parker SE, et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 1993; 259: 1745-9.
14. Yew NS, Wysokenskl DM, Wang KX, et al. Optimization of plasmid vectors for high-level expression in lung epithelial cells. Hum Gene Ther 1997; 8: 575-84.
15. Wahren B. Gene vaccines. Immunotechnology 1996; 2: 77-83.
16. Fynan EF, Webster RG, Fuller DH, Haynes JR, Santoro JC, Robinson HL. DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc Natl Acad Sci USA 1993; 90: 11478-82.
17. Hinkula J, Svanholm C, Schwartz S, et al. Recognition of prominent viral epitopes induced by immunization with human immunodeficiency virus type 1 regulatory genes. J Virol 1997; 71: 5528-39.
18. Wang B, Ugen KE, Srikantan V, et al. Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc Natl Acad Sci USA 1993; 90: 4156-60.
19. Boyer JD, Ugen KE, Wang B, et al. Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination. Nat Med 1997; 3: 526-32.
20. Ugen KE, Boyer JD, Wang B, et al. Facilitated nucleic acid vaccinations of humans with a HIV-1 expressing DNA plasmid boosts immune responses against viral proteins. Abstracts of the Molecular Approaches to the Control of Infectious Diseases Meeting. Cold Spring Harbor Laboratory. Cold Spring Harbour, NY: Cold Spring Harbour Laboratory Press, 1996: 92.